Narrative review / 2013
Evidence supports maintaining 25OHD levels above 20 ng/mL, making recommendations for 30 ng/mL or higher premature.
Authors analyzed published randomized controlled clinical trials to define optimal vitamin D intake and status for bone and extraskeletal health. Apart from reducing falls in the elderly with 800 IU/d of vitamin D3, extraskeletal causality remains unproven in RCTs, though the greatest risk for cancer, infections, cardiovascular, and metabolic diseases associates with 25OHD levels below 20 ng/mL. RCT evidence indicates calcium and bone homeostasis normalizes with 25OHD levels above 20 ng/mL, and 800 IU/d with calcium reduces fracture incidence by about 20%. The authors concluded that a daily intake of 500-700 IU is sufficient to maintain 20 ng/mL, making recommendations for 1500-2000 IU/d or serum levels of 30 ng/mL or higher premature.
- Study type
- Critical narrative review of published RCTs
- Who was studied
- Adults, elderly subjects, and postmenopausal women
- What was measured
- Bone and extraskeletal health outcomes, serum 25OHD levels, falls, and fractures
THE PAPER
Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine.
Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, Lips P. J Clin Endocrinol Metab, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.